Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.


ALTG members Paul Mitchell, Ken O’Byrne and Nick Pavlakis are continuing their contribution to establishing TACT (the Thoracic Alliance for Cancer Trials), the new global collaboration for thoracic oncology clinical research. Paul Mitchell is Chair of the TACT Board while Ken O’Byrne and Nick Pavlakis are Board Members. Applications for membership are now open to academic thoracic oncology research groups and the ALTG will be among the first groups to submit its credentials. A number of pharmaceutical companies have joined the Industry Partner Programme and the website will be launched in the first quarter of 2016. The first TACT General Assembly will take place on June 3 in Chicago, prior to the ASCO Annual Meeting and the second General Assembly is planned for December, to coincide with the 17th WCLC in Vienna.